Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Gastric Intestinal Metaplasia
NCT05288153Phase 4Completed
- Sponsor
- Xijing Hospital of Digestive Diseases
- Start
- Apr 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liquid metformin (Aspargo Labs) in gastric intestinal metaplasia (IM), sponsored by Xijing Hospital of Digestive Diseases. Started Apr 2022; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
gastric intestinal metaplasia (IM)
Beyond the preview
Go deeper on NCT05288153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05288153.